TokenPost·
FDA Grants Accelerated Approval to GSK’s Neladalkib for Lung Cancer

GSK completed its $10.6 billion acquisition of Nuvalent in July, adding three lung cancer assets to its portfolio.
Every crypto headline. One feed. Updated every minute.

GSK completed its $10.6 billion acquisition of Nuvalent in July, adding three lung cancer assets to its portfolio.